# High-Resolution Assessment of Extracranial Plaques in a Multiple Centers Evolocumab Randomized Study

> **NCT05585151** · PHASE4 · UNKNOWN · sponsor: **Union Hospital, Tongji Medical College, Huazhong University of Science and Technology** · enrollment: 200 (estimated)

## Conditions studied

- Cerebral Atherosclerosis

## Interventions

- **DRUG:** Evolocumab 140 MG/ML
- **DRUG:** Intensive statin treatment

## Key facts

- **NCT ID:** NCT05585151
- **Lead sponsor:** Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-11-09
- **Primary completion:** 2024-04-01
- **Final completion:** 2024-10-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2023-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05585151

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05585151, "High-Resolution Assessment of Extracranial Plaques in a Multiple Centers Evolocumab Randomized Study". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05585151. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*